Angiotensin-converting enzyme inhibitor limits pulse-wave velocity and aortic calcification in a rat model of cystic renal disease

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 5, 2011, Pages

  Ng, Keith ^a   Hildreth, Cara M ^a   Avolio, Alberto P ^a   Phillips, Jacqueline K ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Aorta; Arterial; Calcium; Collagen; Elastin; Hypertension; Hypertrophy; Polycystic kidney disease

Indexed keywords

ELASTIN; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; AORTA CALCIFICATION; AORTA DISEASE; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTERY COMPLIANCE; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PULSE WAVE; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 80055085689     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00393.2011     Document Type: Article

References (46)

1. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with Image J. Biophoton Int 11: 36-42, 2004.
2. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy BI, Safar ME, Benetos A. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 23: 74-82, 1994.
3. Alsac JM, Journe C, Louedec L, Dai J, Julia P, Fabiani JN, Michel JB. Downregulation of remodelling enzymatic activity induced by an angiotensin-converting enzyme inhibitor (perindopril) reduces the degeneration of experimental abdominal aortic aneurysms in a rat model. Eur J Vasc Endovasc Surg 41: 474-480, 2011.
4. Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol 3: 1599-1605, 2008.
5. Armstrong ZB, Boughner DR, Drangova M, Rogers KA. Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model. Cardiovasc Res 90: 165-170, 2011.
6. Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF, O'Rourke MF. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 71: 202-210, 1985.
7. Belz GG. Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Ther 9: 73-83, 1995.
8. Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, Safar ME. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 17: 3196-3201, 1997.
9. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 63: 1852-1860, 2003.
10. Bonde MM, Olsen KB, Erikstrup N, Speerschneider T, Lyngso C, Haunso S, Nielsen MS, Sheikh SP, Hansen JL. The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling. Regul Pept 167: 21-25, 2011.
11. Brassard P, Amiri F, Schiffrin EL. Combined angiotensin II type 1 and 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Hypertension 46: 598-606, 2005.
12. Chang JH, Yoon SJ, Han SH, Shin SK, Jeon DW, Yang JY, Kang EW. The impact of dialysis modality on arterial stiffness in patients with end-stage renal disease. Ren Fail 32: 947-953, 2010.
13. Chung AW, Yang HH, Kim JM, Sigrist MK, Brin G, Chum E, Gourlay WA, Levin A. Arterial stiffness and functional properties in chronic kidney disease patients on different dialysis modalities: an exploratory study. Nephrol Dial Transplant 25: 4031-4041, 2010.
14. Cliff WJ. The aortic tunica media in aging rats. Exp Mol Pathol 13: 172-189, 1970.
15. Cosson E, Herisse M, Laude D, Thomas F, Valensi P, Attali JR, Safar ME, Dabire H. Aortic stiffness and pulse pressure amplification in Wistar-Kyoto and spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 292: H2506-H2512, 2007.
16. Ferrari P. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Nephrology 12: 81-89, 2007.
17. Gomez-Roso M, Montero MJ, Carron R, Sevilla MA. Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril. Br J Pharmacol 158: 1911-1921, 2009.
18. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000.
19. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103: 987-992, 2001.
20. Huang WH, Chen KH, Hsu CW, Chen YC, Hung CC, Huang JY, Lin JL, Yang CW. Residual renal function-one of the factors associated with arterial stiffness in peritoneal dialysis patients. Insight from a retrospective study in 146 peritoneal dialysis patients. Blood Purif 26: 133-137, 2008.
21. Karsner HT. Thickness of aorta media in hypertension. Trans Assoc Am Physicians 53: 54-58, 1938.
22. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 9: 17-22, 1991.
23. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004.
24. Kieffer P, Robert A, Capdeville-Atkinson C, Atkinson J, Lartaud-Idjouadiene I. Age-related arterial calcification in rats. Life Sci 66: 2371-2381, 2000.
25. Lacolley P, Safar ME, Regnault V, Frohlich ED. Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension. Am J Physiol Heart Circ Physiol 297: H1567-H1575, 2009.
26. London GM, Covic A, Goldsmith D, Wiecek A, Suleymanlar G, Ortiz AJ, Massy Z, Lindholm B, Martinez-Castelao A, Fliser D, Agarwal R, Jager KJ, Dekker FW, Blankestijn PJ, Zoccali C, For EUropean REnal and CArdiovascular Medicine Working Group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA). Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow-implications for CKD and cardiovascular disease. Kidney Int Suppl 1: 10-12, 2011.
27. London GM, Marchais SJ, Guerin AP. Arterial stiffness and function in end-stage renal disease. Adv Chronic Kidney Dis 11: 202-209, 2004.
28. Lumpaopong A, Mathew AV, John E, Jelnin V, Benedetti E, Testa G, Oberholzer J, Sankary H, Ruiz C. Early coronary calcification in children and young adults with end-stage renal disease. Transplant Proc 39: 37-39, 2007.
29. McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti J, Whaley-Connell AT, Brenner RM, Bakris GL. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J 156: 277-283, 2008.
30. Ng K, Hildreth CM, Phillips JK, Avolio AP. Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model. Am J Physiol Renal Physiol 300: F1431-F1436, 2011.
31. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, Atkinson J. Calcification of medial elastic fibers and aortic elasticity. Hypertension 29: 999-1006, 1997.
32. Nijdam ME, Plantinga Y, Hulsen HT, Bos WJ, Grobbee DE, van der Schouw YT, Bots ML. Pulse pressure amplification and risk of cardiovascular disease. Am J Hypertens 21: 388-392, 2008.
33. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 46: 200-204, 2005.
34. Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 45: 592-596, 2005.
35. Roach MR, Burton AC. The effect of age on the elasticity of human iliac arteries. Can J Biochem Physiol 37: 557-570, 1959.
36. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension 43: 163-168, 2004.
37. Schiffrin EL. Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature. J Cell Mol Med 14: 1018-1029, 2010.
38. Schiffrin EL, Park JB, Pu Q. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens 20: 71-78, 2002.
39. Shan HY, Bai XJ, Chen XM. Apoptosis is involved in the senescence of endothelial cells induced by angiotensin II. Cell Biol Int 32: 264-270, 2008.
40. Shobeiri N, Adams MA, Holden RM. Vascular calcification in animal models of CKD: a review. Am J Nephrol 31: 471-481, 2010.
41. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H, Ishimura E, Tabata T, Nishizawa Y. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 12: 2117-2124, 2001.
42. Tatchum-Talom R, Niederhoffer N, Amin F, Makki T, Tankosic P, Atkinson J. Aortic stiffness and left ventricular mass in a rat model of isolated systolic hypertension. Hypertension 26: 963-970, 1995.
43. Temmar M, Liabeuf S, Renard C, Czernichow S, Esper NE, Shahapuni I, Presne C, Makdassi R, Andrejak M, Tribouilloy C, Galan P, Safar ME, Choukroun G, Massy Z. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 28: 163-169, 2010.
44. Vlachopoulos C, Alexopoulos N, Stefanadis C. Aortic stiffness: prime time for integration into clinical practice? Hellenic J Cardiol 51: 385-390, 2010.
45. Wang M, Khazan B, Lakatta EG. Central arterial aging and angiotensin II signaling. Curr Hypertens Rev 6: 266-281, 2010.
46. Wolinsky H. Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Morphological and chemical studies. Circ Res 30: 301-309, 1972.